Cargando…
595. Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes
BACKGROUND: Outpatient parenteral antibiotic therapy (OPAT) has reduced length of stay, decreased nosocomial infections, and improved patient satisfaction/outcomes. Factors for choosing candidates and regimens for OPAT include: type of infection, organisms, antibiotic side effects, number of antibio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777404/ http://dx.doi.org/10.1093/ofid/ofaa439.789 |
_version_ | 1783630894192394240 |
---|---|
author | Shah, haroon M Guenther, Erin Dysart, Claire Sherman, Katherine Gundacker, Nathan |
author_facet | Shah, haroon M Guenther, Erin Dysart, Claire Sherman, Katherine Gundacker, Nathan |
author_sort | Shah, haroon M |
collection | PubMed |
description | BACKGROUND: Outpatient parenteral antibiotic therapy (OPAT) has reduced length of stay, decreased nosocomial infections, and improved patient satisfaction/outcomes. Factors for choosing candidates and regimens for OPAT include: type of infection, organisms, antibiotic side effects, number of antibiotics and frequency of administration. This study sought to evaluate if antibiotic type, frequency, and duration, are associated with complications, and particularly if vancomycin is associated with an increase rate of complication. METHODS: Retrospective chart review of Zablocki VA Medical Center patients, Milwaukee, WI discharged from 2013-2017 on OPAT evaluated types of infection, antimicrobial regimens, number of antibiotics, duration, frequency, adverse events and outcomes. Primary outcome analyzed was whether or not there was a complication. Complication defined as antibiotic change/dose adjustment, PICC line complication, or additional clinic/hospital visit RESULTS: 294 cases identified during study period. 286 (95.7%) were male. Most common antibiotics were vancomycin (78; 26.53%), daptomycin (42;14.9%) ertapenem (81, 27.55%), cefazolin (24;8.16%) and ceftriaxone (50;17%). Staphylococcus and Streptococcus were the most common organisms at 42.86% and 22.79% respectively. Univariate analysis of the most common antibiotics, maximum frequency and duration are summarized in table 1. A multivariable found cephalosporins were associated with no complication (OR 2.23, CI 1.20-4.35), and Vancomycin (OR 0.20, CI 0.11-0.36) and Gentamicin (OR 0.06, CI 0.06-0.58) were significantly associated with complication. Antibiotic frequency, duration, bacterial speciation were associated with no complication when controlling for antibiotic type Table 1 [Image: see text] CONCLUSION: Antibiotics given for longer durations or require more frequent monitoring like vancomycin may have higher rates of complications. This study supports the hypothesis that vancomycin and aminoglycosides are associated with complications even when controlling for duration and frequency; cephalosporins are associated with no complication. New, safer antibiotics like long acting lipoglycopeptides may provide alternatives to Vancomycin to diminish the burden on ancillary OPAT staff who deal with OPAT complications. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-7777404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77774042021-01-07 595. Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes Shah, haroon M Guenther, Erin Dysart, Claire Sherman, Katherine Gundacker, Nathan Open Forum Infect Dis Poster Abstracts BACKGROUND: Outpatient parenteral antibiotic therapy (OPAT) has reduced length of stay, decreased nosocomial infections, and improved patient satisfaction/outcomes. Factors for choosing candidates and regimens for OPAT include: type of infection, organisms, antibiotic side effects, number of antibiotics and frequency of administration. This study sought to evaluate if antibiotic type, frequency, and duration, are associated with complications, and particularly if vancomycin is associated with an increase rate of complication. METHODS: Retrospective chart review of Zablocki VA Medical Center patients, Milwaukee, WI discharged from 2013-2017 on OPAT evaluated types of infection, antimicrobial regimens, number of antibiotics, duration, frequency, adverse events and outcomes. Primary outcome analyzed was whether or not there was a complication. Complication defined as antibiotic change/dose adjustment, PICC line complication, or additional clinic/hospital visit RESULTS: 294 cases identified during study period. 286 (95.7%) were male. Most common antibiotics were vancomycin (78; 26.53%), daptomycin (42;14.9%) ertapenem (81, 27.55%), cefazolin (24;8.16%) and ceftriaxone (50;17%). Staphylococcus and Streptococcus were the most common organisms at 42.86% and 22.79% respectively. Univariate analysis of the most common antibiotics, maximum frequency and duration are summarized in table 1. A multivariable found cephalosporins were associated with no complication (OR 2.23, CI 1.20-4.35), and Vancomycin (OR 0.20, CI 0.11-0.36) and Gentamicin (OR 0.06, CI 0.06-0.58) were significantly associated with complication. Antibiotic frequency, duration, bacterial speciation were associated with no complication when controlling for antibiotic type Table 1 [Image: see text] CONCLUSION: Antibiotics given for longer durations or require more frequent monitoring like vancomycin may have higher rates of complications. This study supports the hypothesis that vancomycin and aminoglycosides are associated with complications even when controlling for duration and frequency; cephalosporins are associated with no complication. New, safer antibiotics like long acting lipoglycopeptides may provide alternatives to Vancomycin to diminish the burden on ancillary OPAT staff who deal with OPAT complications. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777404/ http://dx.doi.org/10.1093/ofid/ofaa439.789 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Shah, haroon M Guenther, Erin Dysart, Claire Sherman, Katherine Gundacker, Nathan 595. Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes |
title | 595. Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes |
title_full | 595. Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes |
title_fullStr | 595. Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes |
title_full_unstemmed | 595. Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes |
title_short | 595. Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes |
title_sort | 595. characteristics of antimicrobials which affect parenteral antibiotic therapy outcomes |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777404/ http://dx.doi.org/10.1093/ofid/ofaa439.789 |
work_keys_str_mv | AT shahharoonm 595characteristicsofantimicrobialswhichaffectparenteralantibiotictherapyoutcomes AT guenthererin 595characteristicsofantimicrobialswhichaffectparenteralantibiotictherapyoutcomes AT dysartclaire 595characteristicsofantimicrobialswhichaffectparenteralantibiotictherapyoutcomes AT shermankatherine 595characteristicsofantimicrobialswhichaffectparenteralantibiotictherapyoutcomes AT gundackernathan 595characteristicsofantimicrobialswhichaffectparenteralantibiotictherapyoutcomes |